uMotif Appoints James Thatcher Chief Commercial Officer
uMotif – one of the fastest growing companies in the clinical trial technology market – continues to attract top talent to its leadership...
Read disclosure →Corporate Disclosures & Press Wire (2)
uMotif CEO Steve Rosenberg, Visionary Clinical Trial Technology Leader, to Retire; Industry Veteran and uMotif COO Andrea Valente to Take on Top Role
uMotif today announced that life sciences technology executive and CEO Steve Rosenberg will retire, effective June 1, 2026. Rosenberg and...
Read disclosure →